FINWIRES · TerminalLIVE
FINWIRES

Wells Fargo Initiates First Tracks Biotherapeutics at Overweight

By

First Tracks Biotherapeutics (TRAX) has an average rating of buy and mean price target of $38.12, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Update: JPMorgan Upgrades Tesla to Neutral From Underweight as 'Vertical Integration & Tech Efficacy Unmatched', $475 Price Target

(Updated to include JPMorgan's commentary)JPMorgan upgraded Tesla (TSLA) to neutral from underweight, noting the company's unmatched vertical integration is a "unique advantage."The EV maker is at the forefront of physical AI, entering uncharted TAMs, and its strong execution will be vital to accelerating adoption and increasing the size of these TAMs themselves, analysts led by Rajat Gupta wrote in a Friday note.Tesla has an average rating of overweight and mean price target of $400.22, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $406.60, Change: $-11.85, Percent Change: -2.83%

$TSLA
Research

JPMorgan Upgrades Tesla to Neutral From Underweight, $475 Price Target

Tesla (TSLA) has an average rating of overweight and mean price target of $400.22, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $413.97, Change: $-4.48, Percent Change: -1.07%

$TSLA
Research

Morgan Stanley Upgrades Inditex to Overweight, Boosts PT

Morgan Stanley on Friday upgraded Spanish clothing retailer Industria de Diseño Textil (ITX.MC), d/b/a Inditex, to overweight from equal weight and raised its price target to 62 euros from 52.50 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ITX.MC